Main Article Content

Apoptotic effect of astaxanthin from white shrimp shells on lung cancer A549 cells

Supita Tanasawet
Wanida Sukketsiri
Pennapa Chonpathompikunlert
Pennapa Chonpathompikunlert
Wanwimol Klaypradit
Morakot Sroyraya
Pilaiwanwadee Hutamekalin


Purpose: To investigate the anti-cancer potential of astaxanthin from Litopenaeus vannamei encapsulated in liposomes (ASX) to treat lung cancer A549 cells.
Methods: Lung adenocarcinoma A549 cells were cultured and treated with ASX, following which cell viability and nuclear staining were performed. Generation of ROS was identified by the DCFH-DA assay while tetramethylrhodamine ethyl ester was used to determine the mitochondrial membrane potential. Flow cytometry was applied to investigate caspase-3/7 activity and cell cycle distribution.
Results: ASX inhibited growth of A549 in a concentration- and time- dependent manner. The IC50 values at 24, 48 and 72 h were 53.73, 22.85, 17.46 μg/mL, respectively (p < 0.05). After incubation with ASX, the morphological changes were observed in A549 cells following Hoechst 33342/PI fluorescent staining. ASX increased ROS generation and was associated with the collapse of mitochondrial membrane potential, which subsequently triggered the activation of caspase-3/7 activity leading to apoptosis (p < 0.05). In addition, A549 cells accumulated in the G0/G1 phase.
Conclusion: The results suggest that ASX is a valuable nutraceutical agent to target A549 lung cancer cells via ROS-dependent pathway as well as blockage of cell cycle progression.

Keywords: Astaxanthin, Litopenaeus vannamei, Lung cancer, A549, Apoptosis

Journal Identifiers

eISSN: 1596-9827
print ISSN: 1596-5996